Medical News
University News
Medical Publications
Resources
Medical News Releases > University Groups > School of Medicine >

Allergy / Immunology


News Stories & Tip Sheets:

Showing Stories 1 through 3 of 51.  - Show More
Immune cell self-destruction

Gene regulates immune cells' ability to harm the body

July 16, 2009 -- A recently identified gene allows immune cells to start the self-destructive processes thought to underlie autoimmune diseases such as multiple sclerosis (MS) and rheumatoid arthritis, researchers at the School of Medicine have found.


Asthma testing

Washington University physicians provide free asthma screening at Science Center

May 11, 2009 -- If you've regularly been coughing, wheezing or short of breath, you may want to get tested for asthma at the Saint Louis Science Center on Saturday, May 16, 2009. As part of a nationwide program, Washington University School of Medicine physicians will be at the Science Center to test lung function and answer questions about asthma. The screenings are free.


Life lessons from an asthma coach

Asthma coaching can reduce hospitalizations in some children

May 4, 2009 -- Working with an asthma coach helps to significantly reduce hospitalizations of low-income, African-American children with asthma, results of a new, two-year study show. Researchers at the School of Medicine and the University of North Carolina at Chapel Hill worked with nearly 200 parents of children between 2-8 years old on Medicaid who had been hospitalized for asthma at St. Louis Children's Hospital.



Showing Stories 1 through 3 of 51.  - Show More

Faculty Experts:

Showing Experts 1 through 5 of 6.  - Show More
Stanford Peng

Assistant professor of internal medicine

Peng is working to uncover the molecular and genetic underpinnings of autoimmune conditions such as lupus, inflammatory bowel disease and some forms of arthritis. His lab was the first to find firm experimental evidence supporting a radical new theory for what immune cells are like when they're not ...


Expertise: lupus, arthritis, inflammatory bowel disease, T cell, B cell, immunology, autoimmunity

Media assistance: (314) 286-0122 / purdym@wustl.edu


John Morris

Director and Principal Investigator, Alzheimer's Disease Research Center, Department of Neurology

John C. Morris, M.D., is the Harvey A. and Dorismae Hacker Friedman Distinguished Professor of Neurology, Professor of Pathology and Immunology and of Physical Therapy, and the Director of the Alzheimer Disease Research Center, Center for Aging, the Memory and Aging Project, and the Memory Diagnostic ...


Expertise: Alzheimer's disease, dementia, memory, aging, mild cognitive impairment

Media assistance: (314) 286-0122 / purdym@wustl.edu


Roy Curtiss

Professor emeritus of biology in Arts & Sciences

Roy Curtiss
Roy Curtiss
Download

Has developed a Salmonella-based oral vaccine for livestock that can free animals from the virulent strain of Salmonella that causes food-poisoning in humans. His vaccine has received FDA approval for swine and poultry and is on the market. Curtiss also has obtained patents for the use of transgenic ...


Expertise: Salmonella, food poisoning, FDA, vaccine, genetic engineering, microbial, pathogen, …

Direct contact: (314) 935-6819 / rcurtiss@wustl.edu


Robert Schreiber

Alumni Endowed Professor of Pathology and Immunology

Our research is aimed at elucidating the molecular cell biology of cytokine receptor signaling and in defining the effects of signaling dysfunction on tumor development. Towards these ends, we are studying the receptors for interferon-gamma (IFNg) and interleukin-10 (IL-10), two related yet distinct ...


Expertise: Tumor immunology; immune system/response

Media assistance: (314) 286-0141 / ericsong@wustl.edu


Steven Teitelbaum

Wilma and Roswell Messing Professor of Pathology and Immunology

Teitelbaum
Teitelbaum

As the past president of the Federation of American Societies for Experimental Biology — the largest coalition of biomedical research associations in the United States — Teitelbaum is a strong supporter for therapeutic cloning. Somatic cell nuclear transfer, as it is also known, could hold the potential ...


Expertise: Experimental biology, therapeutic cloning, osteoporosis, bone degeneration, bone disease

Media assistance: (314) 286-0120 / westerhousej@wustl.edu



Showing Experts 1 through 5 of 6.  - Show More
Related News Clips:

Showing Clips 1 through 5 of 6.  - Show More
Show More Clips
Revealed: Secret allergy triggers
CNNhealth.com and 1 others

June 16, 2009 -- You could blame weeds, trees, and grasses if you start itching, sneezing, coughing, and wheezing this fall. But the usual suspects aren't the only triggers. A host of household items candles, chemicals, stuffed animals, and spices may be the real culprits. Includes advice from WUSTL allergy and immunology professor James Wedner.


Secret allergy triggers -- revealed!
CNN.com

Oct. 29, 2008 -- A look at allergy triggers other than the usual suspects. Includes comments by WUSTL allergy and immunology chief James Wedner.


Camel antibodies aid caffeine test
The Arizona Republic online

July 6, 2006 -- A caffeine detection test developed by WUSTL medical researchers will help people know if their drinks include caffeine.
WUSTL senior scientist Dan Crimmins comments.


A controversial therapy for diabetes is verified
The New York Times, Wall Street Journal, St. Louis Post-Dispatch and 47 others

March 24, 2006 -- Three groups of scientists -- at U Chicago, WUSTL and Harvard -- reported in Science that they independently replicated a controversial finding: severely diabetic mice can recover on their own if researchers squelch an immune system attack that is causing the disease.
It is a discovery that was first published in 2001 and raised the hopes of people with Type 1 diabetes.
The findings also gave rise to questions about using embryonic stem cells as replacement cells for diabetics.
The Post-Dispatch article includes comments from WUSTL immunologist Emil Unanue.


Drug holds hope for some with tough cases of asthma
St. Louis Post-Dispatch and 19 others

May 24, 2005 -- Report on a study conducted by WUSTL and SLU researchers on behalf of drug maker Novartis Pharmaceuticals to test a new therapy against poorly controlled asthma. WUSTL researcher Phillip Korenblat and WUSTL allergy and immunology division chief James Wedner comment.



Washington University in St. LouisSchool of Medicine

Affiliated with Barnes-Jewish Hospital and St. Louis Children's Hospital, members of BJC HealthCare.

Please contact us and let us know how we can assist you.
Technical problems with this Web site? Email questions or comments.
Please review the WUSTL News & Information copyright/privacy policy.













Related Information
Media Assistance:

Jim Dryden
Assoc. Dir. of Broadcast Services
jdryden@wustl.edu

(314) 286-0110
Related Groups:

Schools:
Arts & Sciences
School of Medicine

- View All Groups

Related Topics:
Medical Science

- View All Topics

Revised:

Thursday, Dec. 2, 2004


  Print ready page